Integrating anatomo‐physiological changes and pharmacogenomics in anti‐infective therapy management: is it a major concern? | Zendy

Beaumier Laura | Zendy; Chanoine Sébastien | Zendy; GautierVeyret Elodie | Zendy; Pluchart Hélène | Zendy; Cornet Muriel | Zendy; BrenierPinchart MariePierre | Zendy; Fonrose Xavier | Zendy; Camara Boubou | Zendy; Bedouch Pierrick | Zendy

Premium

Integrating anatomo‐physiological changes and pharmacogenomics in anti‐infective therapy management: is it a major concern?

Author(s) -

Beaumier Laura,

Chanoine Sébastien,

GautierVeyret Elodie,

Pluchart Hélène,

Cornet Muriel,

BrenierPinchart MariePierre,

Fonrose Xavier,

Camara Boubou,

Bedouch Pierrick

Publication year - 2019

Publication title -

british journal of clinical pharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.216

H-Index - 146

eISSN - 1365-2125

pISSN - 0306-5251

DOI - 10.1111/bcp.13785

Subject(s) - medicine , posaconazole , itraconazole , voriconazole , fluconazole , therapeutic drug monitoring , pharmacokinetics , pharmacology , alprazolam , adverse effect , antifungal , psychiatry , anxiety , dermatology

Success of anti-infective therapy is a major challenge in some patients given anatomo-physiological changes and genetic variations. In this case anecdote, we report the management strategy of a patient suffering from chronic pulmonary aspergillosis in a context of anorexia nervosa and genetic polymorphism.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research